QLGN icon

Qualigen Therapeutics

14 hedge funds and large institutions have $614K invested in Qualigen Therapeutics in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
3
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
BBA
1
Baker Bros. Advisors
New York
$220K 400,000
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$161K 293,109 -58,944 -17%
Vanguard Group
3
Vanguard Group
Pennsylvania
$71K 126,429 -36,932 -23%
Creative Planning
4
Creative Planning
Kansas
$55K 100,600 +45,600 +83%
BlackRock
5
BlackRock
New York
$39K 70,219 +10,160 +17%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$16K 29,614
UCFA
7
United Capital Financial Advisors
Texas
$11K 20,000 +10,000 +100%
Royal Bank of Canada
8
Royal Bank of Canada
Ontario, Canada
$7K 12,000
Bank of New York Mellon
9
Bank of New York Mellon
New York
$7K 13,304 +13,304 New
Wells Fargo
10
Wells Fargo
California
$6K 11,000
PFA
11
Paradigm Financial Advisors
Missouri
$6K 10,000 +10,000 New
Citadel Advisors
12
Citadel Advisors
Florida
$6K 10,003 +10,003 New
Millennium Management
13
Millennium Management
New York
$6K 10,680 +10,680 New
Deutsche Bank
14
Deutsche Bank
Germany
$3K 6,614 +6,614 New
KCM
15
Knoll Capital Management
Florida
-802,434 Closed
VKH
16
Virtu KCG Holdings
New York
-105,409 Closed
Citigroup
17
Citigroup
New York
-369 Closed